Angle PLC Announces HER2 Presentation at SABCS
ANGLE Presents Two Posters at EACR
Angle PLC Announces Publication Demonstrates CTC Profiling Potential
Angle Plc Reports 1H Results
Angle PLC Announces 100th Publication Supporting Parsortix System Use
ANGLE SPON ADR EACH REPR 10 ORD (ANPCY.US) will release its financial report on September 26.
$ANGLE SPON ADR EACH REPR 10 ORD (ANPCY.US) will release its financial report on September 26th. Investors are invited to pay attention. Futubull reminder: 1. There is no strict regulation on the division of accounting year for companies listed on the Hong Kong and US stock markets. It is completely determined by the enterprise, so each financial report period can be used as the company's annual report deadline, rather than using the calendar year as the fiscal year. 2. Generally, the company will hold a financial report conference on the above-mentioned financial report release date or nearby dates, where the company's management will present the latest quarterly financial data and operational situation.
Angle PLC Announces Agreement With Recursion Pharmaceuticals
Angle PLC - Data Supporting FDA Approval Published in Journal
Angle PLC Announces Result of 2024 Annual General Meeting
Angle PLC Announces Posting of 2023 Annual Report & Notice of the AGM
Angle PLC Announces Parsortix and Assays Being Showcased at EACR 2024
Angle PLC Announces Study of Ovarian Cancer CTCs Using Parsortix
ANGLE Inks Supplier Agreement With AstraZeneca To Develop A Parsortix-Based Androgen Receptor Detection Assay For Use In Prostate Cancer Studies
Liquid Biopsy Firm Angle Signs New Commercial Agreement With AstraZeneca
ANGLE Achieves Breakthrough With EU Patent for CellKeep Technology, With the US to Follow
Angle PLC Announces Parsortix HER2 Assay Showcased at AACR 2024
Presenting on the Emerging Growth Conference 69 Day 1 on April 3 Register Now
Angle PLC Announces Parsortix at European Breast Cancer Conference
Angle PLC Announces Potential Utility in Precision Oncology
Angle PLC Announces Parsortix Unlocks Opportunities for Drug Discovery
Unlock the Full List